Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
History
Sports
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/1a/69/9b/1a699bfe-2bb8-43e7-c19a-1abddc1bbbf7/mza_9273680668163317928.jpg/600x600bb.jpg
All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier
UCARE, the Global Allergy and Asthma Excellence Network for Urticaria
113 episodes
4 days ago
Since 2020 this podcast is an invaluable resource for health care professionals, and anyone interested in learning more about urticaria. In the first 97 episodes, Prof. Marcus Maurer († 31.07.2024) is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Prof. Torsten Zuberbier has taken on this role. All opinions expressed are those of the faculty. This content should not be taken as medical advice and is for informational purposes only. Learn more about the network and its activities here: https://ucare-network.com/
Show more...
Science
RSS
All content for All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier is the property of UCARE, the Global Allergy and Asthma Excellence Network for Urticaria and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Since 2020 this podcast is an invaluable resource for health care professionals, and anyone interested in learning more about urticaria. In the first 97 episodes, Prof. Marcus Maurer († 31.07.2024) is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Prof. Torsten Zuberbier has taken on this role. All opinions expressed are those of the faculty. This content should not be taken as medical advice and is for informational purposes only. Learn more about the network and its activities here: https://ucare-network.com/
Show more...
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/42928867/42928867-1746512284339-ccd8e4d8bdee8.jpg
The spectrum of cold urticaria
All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier
21 minutes 5 seconds
5 months ago
The spectrum of cold urticaria

⁠In this episode, Prof. Torsten Zuberbier calls up Dr. Hanna Bonnekoh, dermatologist and researcher at Charité Berlin, to dive into the complexities of cold-induced urticaria—particularly rare and familial forms that challenge current diagnostics and treatments. ⁠


They discuss:

🔹 What makes wind-induced cold urticaria so difficult to diagnose?

🔹 How can physicians distinguish between histamine- and IL-1-mediated disease?

🔹 What role do biologics like omalizumab and dupilumab play in treatment?

🔹 Why are IL-1 blockers crucial in autoinflammatory syndromes like Muckle-Wells-syndrome?


Dr. Bonnekoh shares her clinical perspective on diagnostic tools like the TempTest, the pathophysiology behind cold urticaria variants, and how novel therapies like anti-CKIT antibodies are shaping the future of care. She also emphasizes the importance of family history, wheal morphology, and systemic symptoms when evaluating patients with atypical urticaria.

Join us for a deep dive into cold urticaria phenotypes, treatment strategies, and the call for more research and global registry data to support patients worldwide.


Key Learnings from the Episode

Cold urticaria includes rare phenotypes, such as wind-induced and familial forms, often undetectable by standard tests.

The TempTest is useful for threshold diagnosis, but not all cold urticaria types respond.

Histamine-mediated urticaria may respond to antihistamines or omalizumab, while IL-1-mediated types (e.g., Muckle-Wells) require immunomodulatory therapy.

IL-1 plays a key role in autoinflammation; identifying its overproduction is crucial in diagnosis.

CRP and ESR are easy, accessible lab markers to differentiate urticaria types.

New biologics like anti-CKIT antibodies (e.g., barzolvolimab) are promising in depleting mast cells.

Wheal appearance, duration, and sensations (itch vs. burn) help guide subtype classification.

Cold-induced cholinergic urticaria is an emerging phenotype needing further research.

Global registries like CURE are key to improving care for rare urticaria types.


Chapters 

00:00 Introduction to Cold-Induced Problems 

03:29 Understanding Atypical Cold Urticaria 

06:23 Treatment Options for Cold Urticaria 

09:12 Exploring Rare Forms of Cold Urticaria 

11:53 The Role of Interleukin-1 in Cold Urticaria 

14:40 Differential Diagnosis in Cold Urticaria 

17:15 Research and Future Directions in Cold Urticaria 


Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.


Feedback form:

ATU: ⁠⁠⁠⁠https://forms.office.com/e/m6a2uEdsUH

All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier
Since 2020 this podcast is an invaluable resource for health care professionals, and anyone interested in learning more about urticaria. In the first 97 episodes, Prof. Marcus Maurer († 31.07.2024) is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Prof. Torsten Zuberbier has taken on this role. All opinions expressed are those of the faculty. This content should not be taken as medical advice and is for informational purposes only. Learn more about the network and its activities here: https://ucare-network.com/